|
WO2021026316A1
|
|
Acid-labile surfactants
|
|
US2020399660A1
|
|
Modified polyamine polymers for delivery of biomolecules into cells
|
|
US2020370083A1
|
|
Methods using photothermal nanoparticles in rapid nucleic acid amplification and photothermal nanoparticles
|
|
US2020386748A1
|
|
Compositions and methods for analyte detection using bioluminescence
|
|
US2020340982A1
|
|
Photoaffinity probes
|
|
WO2020123792A1
|
|
Polymerase inhibitors and related compositions and methods
|
|
WO2020117954A2
|
|
Broad spectrum gpcr binding agents
|
|
US2020166460A1
|
|
Reactive peptide labeling
|
|
CA3114424A1
|
|
Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof
|
|
US2020062766A1
|
|
Coelenterazine analogues
|
|
WO2020028905A1
|
|
Combination barcode reader and radio frequency identification read/write device
|
|
US2020030456A1
|
|
Quinone-containing conjugates
|
|
EP3807419A2
|
|
Multipartite luciferase
|
|
WO2019236731A1
|
|
Luciferase enzymes for use with thermostable luciferins in bioluminescent assays
|
|
EP3802514A1
|
|
Inhibitors of oplophorus luciferase-derived bioluminescent complexes
|
|
US2020003771A1
|
|
Broad spectrum kinase binding agents
|
|
US2019337939A1
|
|
Nanoluc suicide substrates
|
|
WO2019028272A1
|
|
Compositions and methods for stabilizing benzothiazole luciferin analogs
|
|
US2019010157A1
|
|
Serum stable pro-coelenterazine analogues
|
|
US2019352623A1
|
|
Internal protein tags
|
